vs
Side-by-side financial comparison of Inuvo, Inc. (INUV) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
Inuvo, Inc. is the larger business by last-quarter revenue ($14.3M vs $13.2M, roughly 1.1× TriSalus Life Sciences, Inc.). Inuvo, Inc. runs the higher net margin — -4.2% vs -73.9%, a 69.7% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -45.6%). Inuvo, Inc. produced more free cash flow last quarter ($-339.9K vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -8.5%).
Inuvo, Inc. is a digital marketing technology firm that develops AI-powered advertising solutions. It offers intent-based audience targeting, performance marketing, and brand awareness services for retail, finance, and consumer goods clients, mainly operating across the North American market.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
INUV vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.3M | $13.2M |
| Net Profit | $-593.9K | $-9.8M |
| Gross Margin | 66.4% | 86.7% |
| Operating Margin | -8.5% | -24.8% |
| Net Margin | -4.2% | -73.9% |
| Revenue YoY | -45.6% | 59.8% |
| Net Profit YoY | -520.2% | 3.5% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.3M | $13.2M | ||
| Q3 25 | $22.6M | $11.6M | ||
| Q2 25 | $22.7M | $11.2M | ||
| Q1 25 | $26.7M | $9.2M | ||
| Q4 24 | $26.2M | $8.3M | ||
| Q3 24 | $22.4M | $7.3M | ||
| Q2 24 | $18.2M | $7.4M | ||
| Q1 24 | $17.0M | $6.5M |
| Q4 25 | $-593.9K | $-9.8M | ||
| Q3 25 | $-1.7M | $-10.8M | ||
| Q2 25 | $-1.5M | $-8.3M | ||
| Q1 25 | $-1.3M | $-10.4M | ||
| Q4 24 | $141.3K | $-10.1M | ||
| Q3 24 | $-2.0M | $-2.4M | ||
| Q2 24 | $-1.7M | $-4.3M | ||
| Q1 24 | $-2.1M | $-13.2M |
| Q4 25 | 66.4% | 86.7% | ||
| Q3 25 | 73.4% | 83.5% | ||
| Q2 25 | 75.4% | 83.9% | ||
| Q1 25 | 79.0% | 83.7% | ||
| Q4 24 | 83.1% | 85.3% | ||
| Q3 24 | 88.4% | 86.3% | ||
| Q2 24 | 84.0% | 87.6% | ||
| Q1 24 | 87.7% | 85.0% |
| Q4 25 | -8.5% | -24.8% | ||
| Q3 25 | -7.4% | -77.9% | ||
| Q2 25 | -9.0% | -65.4% | ||
| Q1 25 | -6.6% | -79.9% | ||
| Q4 24 | 0.8% | -91.8% | ||
| Q3 24 | -8.7% | -118.9% | ||
| Q2 24 | -9.3% | -111.0% | ||
| Q1 24 | -12.3% | -180.8% |
| Q4 25 | -4.2% | -73.9% | ||
| Q3 25 | -7.7% | -93.5% | ||
| Q2 25 | -6.6% | -73.9% | ||
| Q1 25 | -4.7% | -113.2% | ||
| Q4 24 | 0.5% | -122.4% | ||
| Q3 24 | -9.1% | -32.6% | ||
| Q2 24 | -9.6% | -58.8% | ||
| Q1 24 | -12.4% | -204.5% |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | $-0.12 | $-0.96 | ||
| Q2 25 | — | $-0.27 | ||
| Q1 25 | $-0.01 | $-0.39 | ||
| Q4 24 | $0.14 | $-0.38 | ||
| Q3 24 | $-0.15 | $-0.12 | ||
| Q2 24 | $-0.01 | $-0.21 | ||
| Q1 24 | $-0.02 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $10.0M | $-33.9M |
| Total Assets | $24.9M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | $2.0M | $16.5M | ||
| Q1 24 | $2.0M | $4.0M |
| Q4 25 | $10.0M | $-33.9M | ||
| Q3 25 | $10.4M | $-26.7M | ||
| Q2 25 | $12.1M | $-19.4M | ||
| Q1 25 | $13.4M | $-34.4M | ||
| Q4 24 | $13.5M | $-25.9M | ||
| Q3 24 | $12.4M | $-20.4M | ||
| Q2 24 | $13.5M | $-25.3M | ||
| Q1 24 | $15.1M | $-36.0M |
| Q4 25 | $24.9M | $35.3M | ||
| Q3 25 | $29.9M | $36.5M | ||
| Q2 25 | $28.7M | $41.3M | ||
| Q1 25 | $31.7M | $28.6M | ||
| Q4 24 | $32.2M | $24.0M | ||
| Q3 24 | $29.0M | $27.5M | ||
| Q2 24 | $28.5M | $32.4M | ||
| Q1 24 | $29.8M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $21.0K | $-2.5M |
| Free Cash FlowOCF − Capex | $-339.9K | $-2.5M |
| FCF MarginFCF / Revenue | -2.4% | -19.1% |
| Capex IntensityCapex / Revenue | 2.5% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.4M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.0K | $-2.5M | ||
| Q3 25 | $-1.6M | $-3.7M | ||
| Q2 25 | $143.7K | $-7.3M | ||
| Q1 25 | $-366.9K | $-4.5M | ||
| Q4 24 | $329.9K | $-5.7M | ||
| Q3 24 | $1.1M | $-10.8M | ||
| Q2 24 | $195.4K | $-13.4M | ||
| Q1 24 | $-1.4M | $-10.9M |
| Q4 25 | $-339.9K | $-2.5M | ||
| Q3 25 | $-2.0M | $-3.9M | ||
| Q2 25 | $-263.1K | $-7.4M | ||
| Q1 25 | $-818.6K | $-5.3M | ||
| Q4 24 | $-117.7K | $-5.8M | ||
| Q3 24 | $584.0K | $-11.0M | ||
| Q2 24 | $-266.3K | $-13.5M | ||
| Q1 24 | $-1.8M | $-10.9M |
| Q4 25 | -2.4% | -19.1% | ||
| Q3 25 | -8.7% | -33.9% | ||
| Q2 25 | -1.2% | -66.1% | ||
| Q1 25 | -3.1% | -57.3% | ||
| Q4 24 | -0.4% | -69.7% | ||
| Q3 24 | 2.6% | -149.9% | ||
| Q2 24 | -1.5% | -183.1% | ||
| Q1 24 | -10.7% | -169.3% |
| Q4 25 | 2.5% | 0.3% | ||
| Q3 25 | 1.7% | 1.9% | ||
| Q2 25 | 1.8% | 0.8% | ||
| Q1 25 | 1.7% | 8.2% | ||
| Q4 24 | 1.7% | 0.6% | ||
| Q3 24 | 2.1% | 2.3% | ||
| Q2 24 | 2.5% | 0.8% | ||
| Q1 24 | 2.8% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.33× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
